DK1206476T3 - 9a-azalider med antibakteriel virkning - Google Patents

9a-azalider med antibakteriel virkning

Info

Publication number
DK1206476T3
DK1206476T3 DK00955256T DK00955256T DK1206476T3 DK 1206476 T3 DK1206476 T3 DK 1206476T3 DK 00955256 T DK00955256 T DK 00955256T DK 00955256 T DK00955256 T DK 00955256T DK 1206476 T3 DK1206476 T3 DK 1206476T3
Authority
DK
Denmark
Prior art keywords
azalides
antibacterial action
antibacterial
action
Prior art date
Application number
DK00955256T
Other languages
Danish (da)
English (en)
Inventor
Yat Sun Or
Robert F Keyes
Zhenkun Ma
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1206476T3 publication Critical patent/DK1206476T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DK00955256T 1999-08-24 2000-07-26 9a-azalider med antibakteriel virkning DK1206476T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38216699A 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
DK1206476T3 true DK1206476T3 (da) 2006-05-15

Family

ID=23507795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00955256T DK1206476T3 (da) 1999-08-24 2000-07-26 9a-azalider med antibakteriel virkning

Country Status (15)

Country Link
EP (1) EP1206476B1 (de)
JP (1) JP2003507487A (de)
AR (1) AR025379A1 (de)
AT (1) ATE315042T1 (de)
AU (1) AU6748500A (de)
BR (1) BR0009101A (de)
CA (1) CA2380455C (de)
CY (1) CY1104996T1 (de)
DE (1) DE60025370T2 (de)
DK (1) DK1206476T3 (de)
ES (1) ES2256030T3 (de)
HK (1) HK1047940B (de)
MX (1) MXPA02001897A (de)
PT (1) PT1206476E (de)
WO (1) WO2001014397A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
US10633407B2 (en) 2014-10-08 2020-04-28 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
EP3273969A4 (de) 2015-03-25 2018-11-21 President and Fellows of Harvard College Makrolide mit modifizierten desosaminzuckern und verwendungen davon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
YU44599B (en) * 1986-09-12 1990-10-31 Pliva Pharm & Chem Works Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
ES2104386T3 (es) * 1993-05-19 1997-10-01 Pfizer Compuesto intermedio para la acitromicina.
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
WO1999000124A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
WO1999000125A1 (en) * 1997-06-27 1999-01-07 Merck & Co., Inc. 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
EP1101769A3 (de) * 1999-11-18 2001-10-24 Pfizer Products Inc. Stickstoff-enthaltend Erythromycin-Derivate

Also Published As

Publication number Publication date
PT1206476E (pt) 2006-05-31
EP1206476B1 (de) 2006-01-04
ES2256030T3 (es) 2006-07-16
JP2003507487A (ja) 2003-02-25
HK1047940A1 (en) 2003-03-14
ATE315042T1 (de) 2006-02-15
CA2380455A1 (en) 2001-03-01
HK1047940B (en) 2006-11-03
DE60025370T2 (de) 2006-09-21
BR0009101A (pt) 2002-02-05
MXPA02001897A (es) 2002-10-31
CA2380455C (en) 2009-06-02
AU6748500A (en) 2001-03-19
AR025379A1 (es) 2002-11-20
EP1206476A1 (de) 2002-05-22
WO2001014397A1 (en) 2001-03-01
DE60025370D1 (de) 2006-03-30
CY1104996T1 (el) 2010-03-03

Similar Documents

Publication Publication Date Title
PT1206469E (pt) Fenil-oxazolidinonas substituidas heterociclicas antibacterianas
ID26056A (id) Popok sekali pakai
ID26389A (id) Popok sekali pakai
NO20016115L (no) Substituerte heterosykelkondenserte gamma-karbolin
PT1224180E (pt) Azois substituidos
NO20015722D0 (no) Antibakterielle forbindelser
PT1218009E (pt) Grandulos de quetiapina
PT1218096E (pt) Microcapsulas de libertacao variavel
NO20020621D0 (no) Antibakterielle midler
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
PT1163256E (pt) Hemi-hidrato de 16-alfa-bromoepiandrosterona
DE60102936D1 (de) Antibakterielle mutiline
ATE248579T1 (de) Synergistische antibakterielle kombination
PT1235566E (pt) Formulacao injectavel de valnemulina
DE50007972D1 (de) Elastische Walze
PT1206476E (pt) 9a-azalidos com actividade antibacteriana
DE10085008T1 (de) Oberflächenbehandlungsdüse
NO20022927L (no) Substituerte pyrrazoler
ID25567A (id) Ulir-jepit dengan bahu-puntir
ATE269311T1 (de) Benzoylpyridazine
PT1190776E (pt) Pulverizador de liquidos
DK1200423T3 (da) Substituerede pehnyluraciler
FI20001519A0 (fi) Pikakartio
NO992540D0 (no) L°ftetralle